Cassava Sciences | PTIE - Koszty Operacyjne





Koszty Operacyjne Zmiana Data
Abbott USD 9.31B 104M 2026-03
Amgen USD 4.78B 1.12B 2026-03
Biogen USD 1.96B 69.6M 2026-03
Cara Therapeutics USD 5.94M 983K 2025-09
Cassava Sciences USD 13.55M 1.69M 2025-12
Eisai JPY 215.74B 15.84B 2026-03
Eli Lilly USD 10.02B 285M 2026-03
Geron USD 52.07M 6.73M 2026-03
J&J USD 17.44B 1.53B 2026-03
Merck USD 18.17B 8.01B 2026-03
Novartis USD 9.29B 507M 2026-03
Novavax USD 126.2M 23.62M 2025-12
Pfizer USD 90.1B 77.19B 2026-03
Roche Holding CHF 21.01B 10.84B 2025-12